Publications by authors named "Sarah J Welsh"

24Publications

Biomarkers Predicting for Response and Relapse with Melanoma Systemic Therapy.

Acta Derm Venereol 2020 Jun;100(11):adv00142

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3497DOI Listing
June 2020

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.

Eur Urol Oncol 2020 04 16;3(2):168-173. Epub 2020 Jan 16.

Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, UCL Division of Surgical and Interventional Science, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euo.2019.12.004DOI Listing
April 2020

A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound.

Eur Urol Focus 2019 Sep 14. Epub 2019 Sep 14.

Cambridge Centre for Health Services Research, University of Cambridge Institute of Public Health, Forvie Site, Robinson Way, Cambridge, UK; Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.09.002DOI Listing
September 2019

Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting.

World J Urol 2018 Mar 18;36(3):417-425. Epub 2017 Dec 18.

Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-017-2154-xDOI Listing
March 2018

Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?

Eur J Cancer 2016 07 24;62:76-85. Epub 2016 May 24.

Melanoma Institute Australia, 40 Rocklands Road, Wollstonecraft, NSW 2065, Australia; The University of Sydney, Sydney, NSW 2006, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.04.005DOI Listing
July 2016

Melanocyte reprogramming requires chromatin and transcription remodelling.

Pigment Cell Melanoma Res 2016 May 3;29(3):260-1. Epub 2016 Mar 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12457DOI Listing
May 2016

Pazopanib for the treatment of renal cell carcinoma.

Future Oncol 2015 ;11(8):1169-79

Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.274DOI Listing
February 2016

Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma.

Ther Adv Med Oncol 2015 Mar;7(2):122-36

Cambridge Cancer Centre Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758834014566428
Publisher Site
http://dx.doi.org/10.1177/1758834014566428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346212PMC
March 2015

The clinical use of granulocyte-colony stimulating factor.

Br J Hosp Med (Lond) 2014 Feb;75(2):C29-32

Academic Clinical Lecturer in Medical Oncology in the Department of Oncology, Cambridge University Health Partners, Addenbrooke’s Hospital, Cambridge.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2014.75.Sup2.C29DOI Listing
February 2014

Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule.

Sci Rep 2013 Sep 30;3:2799. Epub 2013 Sep 30.

UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep02799DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810677PMC
September 2013

Adjuvant therapy in renal cell carcinoma-past, present, and future.

Semin Oncol 2013 Aug;40(4):482-91

Department of Oncology, Cambridge University Biomedical Research Campus, Addenbrooke's Hospital, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.05.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765962PMC
August 2013

A novel series of G-quadruplex ligands with selectivity for HIF-expressing osteosarcoma and renal cancer cell lines.

Bioorg Med Chem Lett 2012 Sep 14;22(18):5984-8. Epub 2012 Jul 14.

UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2012.07.009DOI Listing
September 2012

Management of the patient with neutropenic sepsis.

Br J Hosp Med (Lond) 2012 Jul;73(7):C101-3

Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2012.73.sup7.c101DOI Listing
July 2012

Assessment of the patient with neutropenic sepsis.

Br J Hosp Med (Lond) 2012 Jun;73(6):C89-92

Addenbrooke's Hospital, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2012.73.sup6.c89DOI Listing
June 2012

68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.

Mol Imaging Biol 2011 Aug;13(4):769-75

Department of Nuclear Medicine, Imperial College Healthcare Trust, London, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11307-010-0396-8
Publisher Site
http://dx.doi.org/10.1007/s11307-010-0396-8DOI Listing
August 2011

The hypoxic inducible stress response as a target for cancer drug discovery.

Semin Oncol 2006 Aug;33(4):486-97

Oxford Medical School, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2006.04.011DOI Listing
August 2006

Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors.

Neoplasia 2005 Apr;7(4):324-30

Department of Biochemistry and Molecular Biophysics, University of Arizona Cancer Center, Tucson, AZ 85724, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1501147PMC
http://dx.doi.org/10.1593/neo.04430DOI Listing
April 2005

Hypoxia inducible factor as a cancer drug target.

Curr Cancer Drug Targets 2003 Dec;3(6):391-405

Arizona Cancer Center, 1515 N Campbell Avenue, Tucson, Arizona 85724, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009033481732DOI Listing
December 2003